Absimky

Ustekinumab is a biologic medication used to treat moderate to severe plaque psoriasis and other autoimmune conditions. This intravenous therapy targets specific proteins to help manage symptoms.

Ustekinumab is primarily used for the treatment of moderate to severe plaque psoriasis, a chronic skin condition characterized by red, itchy, and scaly patches. It may also be prescribed for other autoimmune disorders where the immune system attacks healthy tissues. Ustekinumab works by blocking specific proteins involved in the inflammatory process, helping to reduce symptoms and improve quality of life.

Common effects of Ustekinumab may include reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience headaches, nausea, or fatigue. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Ustekinumab should be used with caution in individuals with a history of serious infections or allergic reactions to biologic therapies. It is important to inform your healthcare provider about any current medications or health conditions before starting treatment. Regular monitoring may be required to ensure safety and effectiveness.

Ustekinumab may interact with other medications, particularly those that affect the immune system. It is advisable to avoid live vaccines while using this therapy. Always consult a healthcare provider before combining Ustekinumab with other treatments to minimize potential risks.